文献速递眼底病与葡萄膜炎

玻璃体视网膜生物胶:转化挑战与创新前景

Vitreoretinal bioadhesives: Translational challenges and innovative perspectives.
PubMed 文献 · Prog Retin Eye Res · 2026-08-01

本文综述玻璃体视网膜生物胶在视网膜裂孔和缺陷修复中的转化障碍,指出传统气体和硅油填充主要提供临时腔隙支撑而非直接界面封闭。文章强调不同适应证对黏附性能需求不同,并提出下一代平台应注重适应证特异性功能、可控持久性、术中可递送性和严格临床验证。

要点

  • 玻璃体视网膜生物胶转化受限于湿面黏附不足、残留玻璃体、生物力学不匹配和炎症反应等后节特异性障碍。
  • 外周视网膜裂孔需聚焦封闭和抗液体渗入及牵拉应力,而黄斑裂孔等可能需要支架支持与生物活性平衡。
  • 下一代生物胶应设计为补充容积填充和视网膜固定术的精准眼内平台,而非替代填充。

核心结论

  • 玻璃体视网膜生物胶的转化仍有限,传统气体和硅油填充继续主导视网膜稳定。
  • 未来生物胶应概念化为精准眼内平台,补充容积填充和视网膜固定术,实现界面导向的缺陷封闭、生物调节和可控眼内递送。

研究设计与样本

  • 本文为综述,通过问题驱动、以视网膜为中心的框架,整合临床玻璃体视网膜证据与黏附工程原理。

主要发现

  • 传统气体和硅油填充主要提供临时腔隙支撑而非视网膜缺陷的直接界面封闭,可能需要术后体位、二次干预或带来填充相关并发症。
  • 玻璃体视网膜生物胶的转化受限于后节特异性障碍,包括湿面黏附不足、裂孔边缘残留玻璃体、与柔软神经视网膜的生物力学不匹配、不利的溶胀或降解行为、炎症或增殖反应以及术中精准递送困难。
  • 水凝胶玻璃体替代物可再现天然玻璃体的关键黏弹特性,但主要仍处于研究阶段,提供临时眼内支撑而非直接局灶缺陷修复。

关键数值与推荐

  • 外周视网膜裂孔需要局灶封闭以及抵抗液体渗入和牵拉应力。
  • 黄斑裂孔、视盘小凹黄斑病变和再生性视网膜修复可能需要支架支持、受控生物活性、组织桥接、避免纤维化和长期安全性的不同平衡。

临床怎么用

  • 临床选择视网膜稳定策略时应认识到传统填充的临时支撑性质和潜在并发症。
  • 未来生物胶的临床应用需针对不同适应证评估其功能匹配性、术中可递送性、二次手术兼容性和长期安全性。

局限性

  • 本文为综述,未报告原始研究数据或定量合并结果。
  • 水凝胶玻璃体替代物主要仍处于研究阶段,其临床转化证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bioadhesive materials have been successfully applied across several ophthalmic fields, yet their translation into vitreoretinal surgery for the repair of retinal breaks and defects remains limited. Conventional strategies, including gas and silicone oil tamponade, continue to dominate retinal stabilization; however, they primarily provide temporary cavity-based support rather than direct interfacial closure of retinal defects and may require postoperative positioning, secondary interventions, or carry tamponade-related complications. Despite advances in biomaterial engineering, broader translation of vitreoretinal bioadhesives remains constrained by posterior-segment-specific barriers, including inadequate wet-surface bonding, residual adherent vitreous at retinal break margins, biomechanical mismatch with the compliant neural retina, unfavorable swelling or degradation behavior, inflammatory or proliferative responses, and challenges in precise intraoperative delivery. Importantly, the required adhesive profile differs by indication: peripheral retinal breaks require focal sealing and resistance to fluid ingress and tractional stress, whereas macular holes, optic disc pit maculopathy, and regenerative retinal repair may require different balances of scaffold support, controlled bioactivity, tissue bridging, fibrosis avoidance, and long-term safety. Hydrogel-based vitreous substitutes can reproduce key viscoelastic properties of the native vitreous but remain largely investigational and primarily provide temporary intraocular support rather than direct focal defect repair. Accordingly, next-generation platforms should be designed not simply for adhesion strength, but for indication-specific function, controlled persistence, intraoperative deliverability, secondary-surgery compatibility, and rigorous preclinical and clinical validation. Rather than serving as tamponade replacements, future bioadhesives may be better conceptualized as precision intraocular platforms that complement volumetric tamponade and retinopexy by adding interface-directed defect sealing, biological modulation, and controlled intraocular delivery. This review critically reappraises vitreoretinal bioadhesive strategies, with primary emphasis on retinal detachment and defect repair, through a problem-driven, retina-centered framework that integrates clinical vitreoretinal evidence with adhesion-engineering principles, providing a barrier-oriented translational perspective for interface-directed retinal repair. Building on this analysis, we outline an innovative perspective on the key functional and translational design principles for next-generation vitreoretinal bioadhesives and propose a mechanism-informed roadmap for scalable clinical translation.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Ghalibafan S, Saeed HN, Djalilian AR, et al. Vitreoretinal bioadhesives: Translational challenges and innovative perspectives. Prog Retin Eye Res. 2026. PMID: 42542240. doi:10.1016/j.preteyeres.2026.101506

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。